Lightnews — Scholar-powered news

Kevin Rouault-Pierre @kevinrouault.bsky.social · Jul 21

Congrats @Fadimana Kaya for successfully defending your PhD today after surviving three PhD supervisors 😆 @JudeFitzgibbon @AnaRioMachin and @kevinrouault.bsky.social ! 🎊 🎉

Thank you very much to Profs @Elspeth (Beth) Payne and @Kamil R Kranc for examining Fadimana's thesis!

1 1 7

Kevin Rouault-Pierre @kevinrouault.bsky.social · Jul 9

Thanks for the Podcast Helena Bradbury and Jonathan Sackier. We really enjoyed the discussion! #MDS #SF3B1 #VitaminB5 & #AcademicLife📻 🩸

www.emjreviews.com/hematology/p...

Hema Now: Episode 20: The Science Behind Myelodysplastic Syndromes

Kevin Rouault-Pierre and Onima Chowdhury explore the molecular roots of myelodysplastic syndromes, and their implications for future care.

www.emjreviews.com

4

Reposted by Kevin Rouault-Pierre

Dr Zeinab Rekad 🔬🧬🧪 @zeinabrekad.bsky.social · Jul 8

#RNAsky

Genes & Development @genesdev.bsky.social · Jul 8

📽️ G&D Tapes 📽️

G&D author, Noah Helton tells us about their new study in #genesdev, revealing an intriguing link between stress granule formation and the integrated stress response. #OpenAccess @smslmoon.bsky.social

Read the full story here:
➡️ tinyurl.com/gd352899

2 6

Reposted by Kevin Rouault-Pierre

Celtic Karla @celtickarla.bsky.social · Jun 27

#sciencejobs

Mathew Kiang @mathewkiang.com · Jun 25

Karolinska is looking for 20 (!!) assistant professors and offering 6 year appointments with ~1M USD startup packages.

ki.se/en/about-ki/...

Call for 20 Assistant Professor positions

Karolinska Institutet is a world-leading medical university with a long and proud history of ground-breaking research. We are now recruiting outstanding early-career researchers with particularly exce...

ki.se

2 6

Kevin Rouault-Pierre @kevinrouault.bsky.social · Jun 18

Cannot be prouder!!! @celinephilippe.bsky.social First postdoc of the lab and first to become PI/Group Leader in the best place to study ER and Cancer in France 😁. Looking forward to your science! Truly inspiring! Congratulations and Well done Celine 👏🎉🎊 #ER #Cancer #RNAbiology

Eric Chevet @ericchevet.bsky.social · Jun 17

Welcome to @celinephilippe.bsky.social
in our unit @csignaling.bsky.social who is officially hired as @inserm.fr CRCN. Her projects will explore the connections between #ER_proteostasis and #RNA_metabolism in #Cancer --- BRAVO Céline !!!!!!

1 6

Kevin Rouault-Pierre @kevinrouault.bsky.social · May 24

2

Kevin Rouault-Pierre @kevinrouault.bsky.social · May 24

Thank you for the great discussions and the invitation! Likely one of the best view from a research institute! In the beautiful Barcelona ! Looking forward to future collaborations!

1 2 8

Reposted by Kevin Rouault-Pierre

Josep Carreras Leukaemia Research Institute @carrerasijc.bsky.social · May 20

This Friday, do not miss Dr Rouault-Pierre's Invited Lecture!

💬 "Metabolic intervention in Myelodysplastic Neoplasm; Endoplasmic Reticulum Stress governs a splicing programme in healthy and malignant cells"

🗓️ 23 May, 12pm CEST
📍IJC Auditorium
Online at 👉 us06web.zoom.us/webinar/regi...

3 6

Kevin Rouault-Pierre @kevinrouault.bsky.social · Apr 24

Great work! Well done @francescoterenzi.bsky.social

Kevin Rouault-Pierre @kevinrouault.bsky.social · Apr 23

Many thanks to @hemasphere-journal.bsky.social for their help and support during the whole process!

2

Kevin Rouault-Pierre @kevinrouault.bsky.social · Apr 22

One of our latest! We hope you enjoy! Led by @ShoshanaBurke & in collaboration with @OnimaChowdhury 🎉🎊. #MDS #SF3B1 #VitaminB5 #Leukemia

HemaSphere Journal @hemasphere-journal.bsky.social · Apr 22

📰 "Low-risk MDS—A spotlight on precision medicine for SF3B1-mutated patients"

Despite promising agents like Luspatercept, most patients remain transfusion-dependent. Novel strategies targeting metabolic mis-splicing and oncogenic pathways offer hope for improved outcomes👉https://bit.ly/4hCDiJi

2 2 3

Reposted by Kevin Rouault-Pierre

Nature @nature.com.web.brid.gy · Apr 16

Reply to: Natively expressed AcrIII-1 does not function as an anti-CRISPR protein

Nature, Published online: 16 April 2025; doi:10.1038/s41586-025-08650-7 Reply to: Natively expressed AcrIII-1 does not function as an anti-CRISPR protein

www.nature.com

1 2

Reposted by Kevin Rouault-Pierre

Beth Psaila @bethpsaila.bsky.social · Mar 27

We are recruiting!! Ads now live for a Data Coordinator and 2 Research Assistants/biobankers to join a new @ludwigcancer.bsky.social - @imm.ox.ac.uk joint initiative to prevent progression from early- to advanced blood cancer. Joint posts with Adam Mead+others in Oxford Ludwig. Links below

1 11 16

Reposted by Kevin Rouault-Pierre

Evangelos Giampazolias @giampazolias.bsky.social · Mar 26

💥Exciting new #postdoc opportunities in my lab at @cruk-mi.bsky.social i.bsky.social to study #NutrientHostMicrobiome interactions in #CancerImmunity in mice and humans. #CancerImmunology#MucosalImmunology#Microbiome

⏰Deadline: 4 April 2025
Apply👇
www.cruk.manchester.ac.uk/career/mi-24...

⏩RT

1 17 19

Kevin Rouault-Pierre @kevinrouault.bsky.social · Mar 25

Thanks Diana!

Kevin Rouault-Pierre @kevinrouault.bsky.social · Mar 22

4/4
📖 And fresh off the press in @hemasphere-journal.bsky.social : our new review with @ShoshanaBurke & @OnimaChowdhury— "Low-risk MDS: A spotlight on precision medicine for SF3B1-mutated patients", covering the biological & clinical landscape of SF3B1-MDS.
📢 #MDS #SF3B1

onlinelibrary.wiley...

Low‐risk MDS—A spotlight on precision medicine for SF3B1‐mutated patients

A deep understanding of the biological mechanisms driving the pathogenesis of myelodysplastic neoplasms (MDS) is essential to develop comprehensive therapeutic approaches that will benefit patient's ...

onlinelibrary.wiley.com

1

Kevin Rouault-Pierre @kevinrouault.bsky.social · Mar 22

3/4
📝 Shoshana Burke, Clinical Research Fellow in the lab, wrote a great editorial in @hemasphere-journal.bsky.social on low-risk MDS—it’s a quick 2-minute read!

onlinelibrary.wiley.com/doi/10.1002/...

“Low‐risk” myelodysplastic neoplasm (MDS): Time for a name change?

Click on the article title to read more.

onlinelibrary.wiley.com

1 1

Kevin Rouault-Pierre @kevinrouault.bsky.social · Mar 22

2/4
🔬 Thanks to the #MDSUK Charity, we are developing a Vitamin B5 test and are now working towards a clinical trial based on our findings.

mdspatientsupport.org.uk...

MDS UK Funds Vitamin B5 Tests To Support A Clinical Trial Aiming To Relieve MDS-related Anaemia | MDS UK Patient Support Group

MDS UK funds Vitamin B5 study to alleviate MDS anaemia, led by Oxford University researchers, approved by Birmingham University Cancer Trials, starting Spring 2025.

mdspatientsupport.org.uk

1 1

Kevin Rouault-Pierre @kevinrouault.bsky.social · Mar 22

1/4
🩸 Following up on our work showing that Vitamin B5 can partially rescue ineffective erythropoiesis in SF3B1-MDS, we’ve just published our erythroid differentiation protocol in #JoVE! 🎉 Kudos to @celinephilippe.bsky.social & @ShoshanaBurke for making this happen!

www.jove.com...
www.science...

A Comprehensive Pipeline to Assess the Efficiency of Human Erythropoiesis In Vitro and Ex Vivo

www.jove.com

1 2

Kevin Rouault-Pierre @kevinrouault.bsky.social · Mar 22

Exciting updates from KRP Lab! Since the start of 2025:

2 1 9

Reposted by Kevin Rouault-Pierre

Syed Mian @syedmian.bsky.social · Jan 21

5th Scientific Workshop: the Haematological Tumour Microenvironment and its Therapeutic Targeting

Join us at #TheFrancisCrickInstitute, London, where leading experts from around the globe will discuss the latest research in microenvironment research.

Register now!

www.esh.org/conference/5...

5th Scientific Workshop: the Haematological Tumour Microenvironment and its Therapeutic Targeting | ESH - European School of Haematology

www.esh.org

1 3 6